171 related articles for article (PubMed ID: 6772023)
1. Alpha-locus hexosaminidase genetic compound with juvenile gangliosidosis phenotype: clinical, genetic, and biochemical studies.
Johnson WG; Cohen CS; Miranda AF; Waran SP; Chutorian AM
Am J Hum Genet; 1980 Jul; 32(4):508-18. PubMed ID: 6772023
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of adult-onset and chronic GM2 gangliosidoses in patients of Ashkenazi Jewish origin: substitution of serine for glycine at position 269 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Kaback MM; Neufeld EF
Proc Natl Acad Sci U S A; 1989 Apr; 86(7):2413-7. PubMed ID: 2522660
[TBL] [Abstract][Full Text] [Related]
3. Genetic complementation in somatic cell hybrids of four variants of infantile GM2 gangliosidosis.
Sonderfeld S; Brendler S; Sandhoff K; Galjaard H; Hoogeveen AT
Hum Genet; 1985; 71(3):196-200. PubMed ID: 2933318
[TBL] [Abstract][Full Text] [Related]
4. Inheritance of the enzyme defect in a new hexosaminidase deficiency disease.
Johnson WG; Chutorian AB
Ann Neurol; 1978 Nov; 4(5):399-403. PubMed ID: 104655
[TBL] [Abstract][Full Text] [Related]
5. Apoptotic cell death in mouse models of GM2 gangliosidosis and observations on human Tay-Sachs and Sandhoff diseases.
Huang JQ; Trasler JM; Igdoura S; Michaud J; Hanal N; Gravel RA
Hum Mol Genet; 1997 Oct; 6(11):1879-85. PubMed ID: 9302266
[TBL] [Abstract][Full Text] [Related]
6. The mutation mechanism causing juvenile-onset Tay-Sachs disease among Lebanese.
Hechtman P; Boulay B; Bayleran J; Andermann E
Clin Genet; 1989 May; 35(5):364-75. PubMed ID: 2527097
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and molecular aspects of late-onset GM2-gangliosidosis: B1 variant as a prototype.
Suzuki K; Vanier MT
Dev Neurosci; 1991; 13(4-5):288-94. PubMed ID: 1840099
[TBL] [Abstract][Full Text] [Related]
8. Late onset GM2 gangliosidosis: an alpha-locus genetic compound with near normal hexosaminidase activity.
Charrow J; Inui K; Wenger DA
Clin Genet; 1985 Jan; 27(1):78-84. PubMed ID: 3156697
[TBL] [Abstract][Full Text] [Related]
9. Two abnormalities of hexosaminidase A in clinically normal individuals.
Grebner EE; Mansfield DA; Raghavan SS; Kolodny EH; d'Azzo A; Neufeld EF; Jackson LG
Am J Hum Genet; 1986 Apr; 38(4):505-14. PubMed ID: 2939713
[TBL] [Abstract][Full Text] [Related]
10. Clinical and genetic variations in the syndrome of adult GM2 gangliosidosis resulting from hexosaminidase A deficiency.
Argov Z; Navon R
Ann Neurol; 1984 Jul; 16(1):14-20. PubMed ID: 6235771
[TBL] [Abstract][Full Text] [Related]
11. Juvenile progressive dystonia: a new phenotype of GM2 gangliosidosis.
Meek D; Wolfe LS; Andermann E; Andermann F
Ann Neurol; 1984 Apr; 15(4):348-52. PubMed ID: 6430210
[TBL] [Abstract][Full Text] [Related]
12. Juvenile GM2 gangliosidosis caused by substitution of histidine for arginine at position 499 or 504 of the alpha-subunit of beta-hexosaminidase.
Paw BH; Moskowitz SM; Uhrhammer N; Wright N; Kaback MM; Neufeld EF
J Biol Chem; 1990 Jun; 265(16):9452-7. PubMed ID: 2140574
[TBL] [Abstract][Full Text] [Related]
13. Detection of GM2-gangliosidosis (Tay-Sachs and Sandhoff disease) gene carriers by serum hexosaminidase assay.
Molzer B; Bernheimer H
Clin Chim Acta; 1976 Nov; 73(1):163-9. PubMed ID: 826357
[TBL] [Abstract][Full Text] [Related]
14. Characterization of unusual hexosaminidase A (HEX A) deficient human mutants.
O'Brien JS; Tennant L; Veath ML; Scott CR; Bucknall WE
Am J Hum Genet; 1978 Nov; 30(6):602-8. PubMed ID: 747188
[TBL] [Abstract][Full Text] [Related]
15. Ganglioside GM2 N-acetyl-beta-D-galactosaminidase activity in cultured fibroblasts of late-infantile and adult GM2 gangliosidosis patients and of healthy probands with low hexosaminidase level.
Conzelmann E; Kytzia HJ; Navon R; Sandhoff K
Am J Hum Genet; 1983 Sep; 35(5):900-13. PubMed ID: 6614006
[TBL] [Abstract][Full Text] [Related]
16. Hexosaminidase isozyme in type O Gm2 gangliosidosis (Sandhoff-Jatzkewitz disease).
Beutler E; Kuhl W; Comings D
Am J Hum Genet; 1975 Sep; 27(5):628-38. PubMed ID: 808963
[TBL] [Abstract][Full Text] [Related]
17. Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5 mutation (Tyr180-->His) in the Hex A alpha-chain gene.
De Gasperi R; Gama Sosa MA; Battistini S; Yeretsian J; Raghavan S; Zelnik N; Leshinsky E; Kolodny EH
Neurology; 1996 Aug; 47(2):547-52. PubMed ID: 8757036
[TBL] [Abstract][Full Text] [Related]
18. GM2 gangliosidoses in Spain: analysis of the HEXA and HEXB genes in 34 Tay-Sachs and 14 Sandhoff patients.
Gort L; de Olano N; MacĂas-Vidal J; Coll MA;
Gene; 2012 Sep; 506(1):25-30. PubMed ID: 22789865
[TBL] [Abstract][Full Text] [Related]
19. Hereditary heat-labile hexosaminidase B: a variant whose homozygotes synthesize a functional HEX A.
Navon R; Kopel R; Nutman J; Frisch A; Conzelmann E; Sandhoff K; Adam A
Am J Hum Genet; 1985 Jan; 37(1):138-46. PubMed ID: 3156493
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]